NCT06343311
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06343311
Title T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) (STARLIGHT-1)
Acronym STARLIGHT-1
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Estrella Immunopharma, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, Davis RECRUITING Sacramento California 95817 United States Details
University Hospitals Seidman Cancer Center RECRUITING Cleveland Ohio 44106 United States Details
Oregon Health and Sciences University RECRUITING Portland Oregon 97239 United States Details
Baylor Scott & White Research Institute, Texas Oncology RECRUITING Dallas Texas 75246 United States Details
Intermountain Health, Canyons Region, LDS Hospital RECRUITING Salt Lake City Utah 84143 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field